All In Biotech

Drug Trial Radar · NCT03077711

Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs

Last checked: Nov 19, 2026Latest source record: Jan 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

92

Actual

Start

Jun 2016

Primary completion

Jun 21, 2019

Study completion Jun 21, 2019

Sponsor

Lead sponsor
Endeavor HealthAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 13, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 99 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Several methods are available for use in the prevention of recurrent urinary tract infections (UTIs) over the past few decades. These methods include suppressive antibiotics, estrogen cream, methenamine hippurate, d-mannose, cranberry, probiotics, and vitamin C. Of these, the majority of the literature is in favor of use of suppressive antibiotics for preventing UTIs. However, this data is now about 10 years old. Increasing use of antibiotics over the years has lead to increased resistance of bacteria. In addition, long-term antibiotic use has several adverse effects, some life-threatening. There is recent literature evaluating the use of several of the alternatives to suppressive antibiotics with mixed results. A comparative study of the efficacy of methenamine hippurate to suppressive antibiotics is lacking in the current literature. Several early partly-randomized trials done with methenamine hippurate have shown promising results, but are only as recent as 1987. The primary objective of this prospective, randomized study is to determine whether there is a significant difference in the prevention of recurrent UTIs when given either methenamine hippurate or daily suppressive antibiotics. The secondary objective of this study is to determine how well patients are able to tolerate each of these medications and what adverse effects are observed in a given 1 year time period. The long-term goals of this study are to find an alternative to using suppressive antibiotics, potentially with a lower adverse effect profile and less of the dangers of long term antibiotic use. Finding an alternative to suppressive antibiotics would also tackle the issue of antibiotic resistance.

Conditions

  • Urinary Tract Infections, Recurrent

Interventions

  • TrimethoprimDrug

    suppressive antibiotic. Estrogen cream may be prescribed if the patient is post-menopausal (but not as a part of this study).

  • Methenamine hippurateDrug

    antiseptic used in the prevention of recurrent UTIs. Estrogen cream may be prescribed if the patient is post-menopausal (but not as a part of this study).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Subsequent Infection as Defined From Time of Treatment Initiation to Recurrence of UTITime frame: up to 12 months
  2. Recurrent UTITime frame: up to 12 months
  3. Number of InfectionsTime frame: up to 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • NorthShore Univeristy HealthSystem

    Skokie, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.